| Total Revenue | | 0 |
| Cost of Goods Sold Incl. D&A | | 1 |
| Gross Profit | | -1 |
| Selling, General and Administrative Excl. Other | | 12 |
| Research and Development | | 29 |
| Other Operating Expense | | 0 |
| Operating Income | | -41 |
| Interest Expense | | 0 |
| Unusual Expense | | — |
| Non-Operating Income (Expense) | | -2 |
| Net Income Before Taxes | | -40 |
| Income Taxes | | 0 |
| Consolidated Net Income | | -40 |
| Net Income From Continuing Operations | | -40 |
| Net Income | | -40 |
| EPS (Recurring) | | -1.19 |
| EPS (Basic, Before Extraordinaries) | | -1.19 |
| EPS (Diluted) | | -1.19 |
| EBITDA | | -39 |
| Other After Tax Adjustments | | — |
| Stock Option Compensation Expense | | — |
| Price To Earnings Ratio | | — |
| Price To Sales Ratio | | — |
| Gross Margin | | — |
| Operating Margin | | — |
| Net Margin | | — |
| Shares Outstanding | | 33 |
| Market Capitalization | | — |
| Operating Lease Expense | | — |
